Literature DB >> 14604499

The value of digital imaging in diabetic retinopathy.

P F Sharp1, J Olson, F Strachan, J Hipwell, A Ludbrook, M O'Donnell, S Wallace, K Goatman, A Grant, N Waugh, K McHardy, J V Forrester.   

Abstract

OBJECTIVES: To assess the performance of digital imaging, compared with other modalities, in screening for and monitoring the development of diabetic retinopathy.
DESIGN: All imaging was acquired at a hospital assessment clinic. Subsequently, study optometrists examined the patients in their own premises. A subset of patients also had fluorescein angiography performed every 6 months.
SETTING: Research clinic at the hospital eye clinic and optometrists' own premises. PARTICIPANTS: Study comprised 103 patients who had type 1 diabetes mellitus, 481 had type 2 diabetes mellitus and two had secondary diabetes mellitus; 157 (26.8%) had some form of retinopathy ('any') and 58 (9.9%) had referable retinopathy.
INTERVENTIONS: A repeat assessment was carried out of all patients 1 year after their initial assessment. Patients who had more severe forms of retinopathy were monitored more frequently for evidence of progression. MAIN OUTCOME MEASURES: Detection of retinopathy, progression of retinopathy and determination of when treatment is required.
RESULTS: Manual grading of 35-mm colour slides produced the highest sensitivity and specificity figures, with optometrist examination recording most false negatives. Manual and automated analysis of digital images had intermediate sensitivity. Both manual grading of 35-mm colour slides and digital images gave sensitivities of over 90% with few false positives. Digital imaging produced 50% fewer ungradable images than colour slides. This part of the study was limited as patients with the more severe levels of retinopathy opted for treatment. There was an increase in the number of microaneurysms in those patients who developed from mild to moderate. There was no difference between the turnover rate of either new or regressed microaneurysms for patients with mild or with sight-threatening retinopathy. It was not possible in this study to ascertain whether digital imaging systems determine when treatment is warranted.
CONCLUSIONS: In the context of a national screening programme for referable retinopathy, digital imaging is an effective method. In addition, technical failure rates are lower with digital imaging than conventional photography. Digital imaging is also a more sensitive technique than slit-lamp examination by optometrists. Automated grading can improve efficiency by correctly identifying just under half the population as having no retinopathy. Recommendations for future research include: investigating whether the nasal field is required for grading; a large screening programme is required to ascertain if automated grading can safely perform as a first-level grader; if colour improves the performance of grading digital images; investigating methods to ensure effective uptake in a diabetic retinopathy screening programme.

Entities:  

Mesh:

Year:  2003        PMID: 14604499     DOI: 10.3310/hta7300

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  11 in total

1.  Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs.

Authors:  Kevin Tozer; Maria A Woodward; Paula A Newman-Casey
Journal:  J Endocrinol Diabetes       Date:  2015-11-11

2.  Routine Orthoptic-led Paediatric Fundus Digital Imaging: Benefits to Patients and Healthcare System.

Authors:  Laura B Ramm; Clare Bradbury; Manoj V Parulekar
Journal:  Br Ir Orthopt J       Date:  2018-04-24

3.  Rapid grading of fundus photographs for diabetic retinopathy using crowdsourcing.

Authors:  Christopher J Brady; Andrea C Villanti; Jennifer L Pearson; Thomas R Kirchner; Omesh P Gupta; Chirag P Shah
Journal:  J Med Internet Res       Date:  2014-10-30       Impact factor: 5.428

4.  Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening.

Authors:  V Manjunath; V Papastavrou; D H W Steel; G Menon; R Taylor; T Peto; J Talks
Journal:  Eye (Lond)       Date:  2015-01-16       Impact factor: 3.775

5.  Assessment of Training Outcomes of Nurse Readers for Diabetic Retinopathy Telescreening: Validation Study.

Authors:  Marie Carole Boucher; Michael Trong Duc Nguyen; Jenny Qian
Journal:  JMIR Diabetes       Date:  2020-04-07

6.  Trends in diabetic retinopathy screening attendance and associations with vision impairment attributable to diabetes in a large nationwide cohort.

Authors:  J G Lawrenson; E Bourmpaki; C Bunce; I M Stratton; P Gardner; J Anderson
Journal:  Diabet Med       Date:  2020-11-01       Impact factor: 4.359

7.  Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.

Authors:  Maria Luisa Ribeiro; Sandrina G Nunes; José G Cunha-Vaz
Journal:  Diabetes Care       Date:  2012-11-30       Impact factor: 19.112

Review 8.  Interventions to increase attendance for diabetic retinopathy screening.

Authors:  John G Lawrenson; Ella Graham-Rowe; Fabiana Lorencatto; Jennifer Burr; Catey Bunce; Jillian J Francis; Patricia Aluko; Stephen Rice; Luke Vale; Tunde Peto; Justin Presseau; Noah Ivers; Jeremy M Grimshaw
Journal:  Cochrane Database Syst Rev       Date:  2018-01-15

9.  IT-supported skill-mix change and standardisation in integrated eyecare: lessons from two screening projects in The Netherlands.

Authors:  Marleen de Mul; Antoinette de Bont; Marc Berg
Journal:  Int J Integr Care       Date:  2007-05-16       Impact factor: 5.120

10.  Barriers and enablers to diabetic retinopathy screening attendance: Protocol for a systematic review.

Authors:  Ella Graham-Rowe; Fabiana Lorencatto; John G Lawrenson; Jennifer Burr; Jeremy M Grimshaw; Noah M Ivers; Tunde Peto; Catey Bunce; Jill J Francis
Journal:  Syst Rev       Date:  2016-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.